Skip to content
DefDex

Federal award

ROCHE DIAGNOSTICS CORPORATION

HT001416F0038

Contract

Obligated and Ceiling

Obligated (net)
$279,133.32
Ceiling (potential value, not spending)
$279,133.32
Current value
$279,133.32
Gross positive obligations
$320,624.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
FOUNDATION MEDICINE, INC. · EHXPZ92G4AD1
Awarding agency
Department of War · sub-agency 97DH · office HT0014
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
HT001416F0038
Parent vehicle (IDV PIID)
V797P5279B
Award type code
C
Actions
13 · Jan 28, 2016 to Sep 21, 2021
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History13

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 21, 2021FY2021P00012M−$36,868.84
—
Aug 2, 2021FY2021P00011M$0.00
—
Jan 13, 2020FY2020P00010M$64,124.80
—
Aug 30, 2019FY2019P00009G$0.00
—
May 6, 2019FY2019P00008M−$4,621.84
—
Dec 13, 2018FY2019P00007C$64,124.80
—
Aug 30, 2018FY2018P00006G$0.00
—
Nov 21, 2017FY2018P00005M$64,124.80
—
Sep 29, 2017FY2017P00004G$0.00
—
Oct 17, 2016FY2017P00003C$64,124.80
—
Sep 7, 2016FY2016P00002G$0.00
—
Feb 11, 2016FY2016P00001M$0.00
—
Jan 28, 2016FY20160—$64,124.80
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.